Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Feasibility and preliminary outcomes of a remotely-delivered exercise training intervention for English-speaking Hispanics/Latinos with multiple sclerosis: Results from the FERLA MS study.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: December 10, 2025
The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosis.
Journal: Scientific reports
Published: July 02, 2025
Correction: Rationale for a 4-month, parallel-group, randomized controlled trial to assess the Feasibility and Efficacy of a Remotely delivered exercise training intervention for Hispanics/Latinos with Multiple Sclerosis (FERLA MS).
Journal: Pilot and feasibility studies
Published: June 20, 2025
Rationale for a 4-month, parallel-group, randomized controlled trial to assess the Feasibility and Efficacy of a Remotely delivered exercise training intervention for Hispanics/Latinos with Multiple Sclerosis (FERLA MS).
Journal: Pilot and feasibility studies
Published: November 11, 2024
COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review.
Journal: Neurology and therapy
Published: July 19, 2024
Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls.
Journal: Multiple sclerosis and related disorders
Published: April 13, 2021
CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosis.
Journal: Neurodegenerative disease management
Published: February 01, 2021
Non-invasive brain stimulation to assess neurophysiologic underpinnings of lower limb motor impairment in multiple sclerosis.
Journal: Journal of neuroscience methods
Published: January 18, 2021
Anti-JCV antibody index does not change during ocrelizumab-treatment.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: July 22, 2020
Progressive multifocal leukoencephalopathy and granule cell neuronopathy with novel mutation flanking VP1 C-terminus in natalizumab-extended interval dosing.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 05, 2019
Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.
Journal: Neurology
Published: June 01, 2018
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis.
Journal: Therapeutic advances in neurological disorders
Published: May 08, 2018
Last Updated: 09/26/2026